HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel degradation signal derived from distal C-terminal frameshift mutations of KCNQ2 protein which cause neonatal epilepsy.

Abstract
Benign familial neonatal convulsions is an autosomal-dominant idiopathic form of epilepsy primarily caused by gene mutations of the voltage-gated Kv7.2/KCNQ2/M-channel that exert only partial dominant-negative effects. However, the mechanism underlying the incomplete dominance of channel mutations, which cause epilepsy in infancy, remains unknown. Using mutagenesis and biochemistry combined with electrophysiology, we identified a novel degradation signal derived from distal C-terminal frameshift mutations, which impairs channel function. This degradation signal, transferable to non-channel CD4, can lead to accelerated degradation of mutant proteins through ubiquitin-independent proteasome machinery but does not affect mRNA quantity and protein trafficking. Functional dissection of this signal has revealed a key five-amino acid (RCXRG) motif critical for degradation. Taken together, our findings reveal a mechanism by which proteins that carry this signal are subject to degradation, leading to M-current dysfunction, which causes epilepsy.
AuthorsJun Su, Xu Cao, KeWei Wang
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 286 Issue 50 Pg. 42949-58 (Dec 16 2011) ISSN: 1083-351X [Electronic] United States
PMID21937445 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • KCNQ2 Potassium Channel
Topics
  • Blotting, Western
  • Cell Line
  • Electrophysiology
  • Epilepsy (genetics, metabolism)
  • Frameshift Mutation (genetics)
  • Humans
  • KCNQ2 Potassium Channel (genetics, metabolism)
  • Microscopy, Confocal
  • Microscopy, Fluorescence
  • Real-Time Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: